SCHEMBL6834401

SCHEMBL6834401

N#Cc1ccc(NC(=O)c2noc3cc(NS(=O)(=O)c4ccccc4)ccc23)c(C(=O)O)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR27 Q9NS67 2/20 0.46
AVPR2 P30518 1/20 0.46
ALB P02768 1/20 0.43
MCL1 Q07820 4/20 0.41
CCR2 P41597 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HIF1A Q16665 2/20 0.40
PRSS12 P56730 1/20 0.39
BCL2A1 Q16548 1/20 0.39
HSPD1 P10809 2/20 0.39
PTPN2 P17706 2/20 0.39
PTPN1 P18031 2/20 0.39
PTPN5 P54829 2/20 0.39
HSPE1 P61604 2/20 0.39
METAP2 P50579 1/20 0.39
ALDH1A1 P00352 1/20 0.38
IMPDH2 P12268 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6835759 0.93 GPR27 (0.46) GPR27AVPR2ALBMCL1CCR2
SCHEMBL6818576 0.92 GPR27 (0.46) GPR27AVPR2ALBCCR2MEN1
SCHEMBL6833193 0.88 ALB (0.42) ALBMCL1HIF1A
SCHEMBL6834174 0.88 IMPDH2 (0.41) ALBMCL1CCR2HIF1APTPN2
SCHEMBL6833969 0.86 GPR27 (0.48) GPR27AVPR2ALBMCL1CCR2
SCHEMBL6834095 0.85 GPR27 (0.46) GPR27AVPR2ALBCCR2MEN1
SCHEMBL6814368 0.84 GPR27 (0.46) GPR27AVPR2ALBMCL1CCR2
SCHEMBL6709849 0.84 GPR27 (0.41) GPR27AVPR2HIF1AALDH1A1IMPDH2
SCHEMBL6833073 0.83 ALPL (0.44) ALBHIF1A
SCHEMBL6710333 0.83 GPR27 (0.39) GPR27AVPR2HIF1AHSPD1PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 GPR27 1964/4885AVPR2 4057/4885ALB 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.